Cingulate to Participate in Benzinga All Live Access Event
April 14 2023 - 2:00PM
Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company
utilizing its proprietary Precision Timed Release™ (PTR™) drug
delivery platform technology to build and advance a pipeline of
next-generation pharmaceutical products, today announced that
Chairman and CEO Shane J. Schaffer will participate in a live
Benzinga All Access event on Tuesday April 18, 2023, at 10 a.m.
CST.
The discussion will address the current unmet needs in attention
deficit/hyperactivity disorder (ADHD), as well as the expansion of
Cingulate’s PTR platform into the anxiety therapeutic area.
Dr. Schaffer will also provide a company overview and recap
recent Cingulate clinical and business updates.
The event may be viewed live on Benzinga’s YouTube
channel, Benzinga All Access, and will also
be available for viewing on Cingulate’s website
at cingulate.com/investors.
About
Cingulate® Cingulate Inc. (NASDAQ:
CING), is a biopharmaceutical company utilizing its proprietary
Precision Timed Release™ (PTR™) drug delivery platform technology
to build and advance a pipeline of next-generation pharmaceutical
products, designed to improve the lives of patients suffering from
frequently diagnosed conditions characterized by burdensome daily
dosing regimens and suboptimal treatment outcomes. With an initial
focus on the treatment of Attention Deficit/Hyperactivity Disorder
(ADHD), Cingulate is identifying and evaluating additional
therapeutic areas where PTR technology may be employed to develop
future product candidates, including to treat anxiety
disorders.
Cingulate is headquartered in Kansas City. For more information
visit Cingulate.com
Investor Relations Thomas Dalton Vice
President, Investor & Public Relations,
CingulateTDalton@cingulate.com 913-942-2301
Matt KrepsDarrow
Associatesmkreps@darrowir.com 214-597-8200
Media RelationsMelyssa WeibleElixir Health
Public
Relationsmweible@elixirhealthpr.com 201-723-5805
Cingulate (NASDAQ:CING)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cingulate (NASDAQ:CING)
Historical Stock Chart
From Jul 2023 to Jul 2024